Machine learning models to identify lead compound and substitution optimization to have derived energetics and conformational stability through docking and MD simulations for sphingosine kinase 1

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Molecular diversity

• Publication date

  2024-10-17

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1007/s11030-024-10997-4PMID 39417979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reply to the letter from Dr. Nikolayevskyy et al. referring to our publication published in the Journal of Virological Methods 298 (2021)11:4295 “Evaluation of the QuantiFERON SARS-CoV-2 Interferon-ɣ release assay in mRNA-1273 vaccinated health care workers”

  2022cited by this paper
• Machine learning identifies candidates for drug repurposing in Alzheimer’s disease

  2021cited by this paper
• Investigation of sphingosine kinase 1 inhibitory potential of cinchonine and colcemid targeting anticancer therapy

  2021cited by this paper
• Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approach.

  2021cited by this paper
• Sphingolipids and Kidney Disease: Possible Role of Preeclampsia and Intrauterine Growth Restriction (IUGR).

  2021cited by this paper
• Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer

  2021cited by this paper
• Metformin suppresses vascular smooth muscle cell senescence by promoting autophagic flux

  2021cited by this paper
• Association Between Circulating Linoleic Acid and Risk of Ischemic Stroke

  2021cited by this paper
• Circular RNA CREBBP Suppresses Hepatic Fibrosis Via Targeting the hsa-miR-1291/LEFTY2 Axis

  2021cited by this paper
• Effect of ancillary ligand on DNA and protein interaction of the two Zn (II) and Co (III) complexes: experimental and theoretical study

  2021cited by this paper
• Genome-wide identification and analysis of the PAL genes from the orchids Apostasia shenzhenica, Dendrobium catenatum and Phalaenopsis equestris

  2021cited by this paper
• Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells

  2021cited by this paper
• Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.

  2021cited by this paper
• Identifying Novel Inhibitors for Hepatic Organic Anion Transporting Polypeptides by Machine Learning-Based Virtual Screening

  2021cited by this paper
• Machine learning & deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry.

  2021cited by this paper
• Design and synthesis of new pyrazolylbenzimidazoles as sphingosine kinase-1 inhibitors

  2021cited by this paper
• Protective Effects of Aminooxyacetic Acid on Colitis Induced in Mice with Dextran Sulfate Sodium

  2021cited by this paper
• Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases

  2021cited by this paper
• Comprehensive strategies of machine-learning-based quantitative structure-activity relationship models

  2021cited by this paper
• Machine Learning in Drug Discovery: A Review

  2021cited by this paper
• Virtual Screening of Drug Proteins Based on Imbalance Data Mining

  2021cited by this paper
• Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors

  2021cited by this paper
• Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration

  2021cited by this paper
• Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation

  2021cited by this paper
• Artificial intelligence paradigm for ligand-based virtual screening on the drug discovery of type 2 diabetes mellitus

  2021cited by this paper
• Integrated support vector machine and pharmacophore based virtual screening driven identification of thiophene carboxamide scaffold containing compound as potential PARP1 inhibitor

  2021cited by this paper
• Discovery of Novel Mammalian target of rapamycin (mTOR) Inhibitors by Support Vector Machine

  2021cited by this paper
• Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2

  2021cited by this paper
• Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy

  2021cited by this paper
• Sphingosine kinase 1 regulates lysyl oxidase through STAT3 in hyperoxia-mediated neonatal lung injury

  2021cited by this paper
• Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer

  2021cited by this paper
• Artificial intelligence to deep learning: machine intelligence approach for drug discovery

  2021cited by this paper
• Ozanimod: First Approval

  2020cited by this paper
• Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks

  2020cited by this paper
• Identification of Cancerlectins Using Support Vector Machines With Fusion of G-Gap Dipeptide

  2020cited by this paper
• Applying Machine Learning to Ultrafast Shape Recognition in Ligand-Based Virtual Screening

  2020cited by this paper
• Functional implications of pH-induced conformational changes in the Sphingosine kinase 1.

  2020cited by this paper
• Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition

  2020cited by this paper
• Machine learning classification can reduce false positives in structure-based virtual screening

  2020cited by this paper
• Regulatory role of SphK1 in TLR7/9‐dependent type I interferon response and autoimmunity

  2020cited by this paper
• Sphingosine kinase 1 promotes cerebral ischemia‐reperfusion injury through inducing ER stress and activating the NF‐κB signaling pathway

  2020cited by this paper
• Accelerating high-throughput virtual screening through molecular pool-based active learning

  2020cited by this paper
• Machine Learning Methods in Drug Discovery

  2020cited by this paper
• Transcriptional Regulation of Sphingosine Kinase 1

  2020cited by this paper
• Virtual Screening acetylcholinesterase inhibitors based on machine learning combined with molecule docking methods

  2020cited by this paper
• Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19

  2020cited by this paper
• Convolutional architectures for virtual screening

  2020cited by this paper
• Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3β Inhibitors

  2020cited by this paper
• Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development

  2020cited by this paper
• Insights into Machine Learning-based approaches for Virtual Screening in Drug Discovery: Existing strategies and streamlining through FP-CADD.

  2020cited by this paper
• Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy

  2020cited by this paper
• Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine Kinase 1

  2020cited by this paper
• Targeting mPGES-1 by a Combinatorial Approach: Identification of the Aminobenzothiazole Scaffold to Suppress PGE2 Levels.

  2020cited by this paper
• Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy.

  2019cited by this paper
• Applications of machine learning in drug discovery and development

  2019cited by this paper
• In silico Inhibition of BACE-1 by Selective Phytochemicals as Novel Potential Inhibitors: Molecular Docking and DFT Studies.

  2019cited by this paper
• SPHK1 Is a Novel Target of Metformin in Ovarian Cancer

  2019cited by this paper
• Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer

  2019cited by this paper
• Ligand based virtual screening using SVM on GPU

  2019cited by this paper
• Roles of sphingosine-1-phosphate signaling in cancer

  2019cited by this paper
• Targeting sphingosine kinase 1 for the treatment of pulmonary arterial hypertension.

  2019cited by this paper
• Deep learning enables rapid identification of potent DDR1 kinase inhibitors

  2019cited by this paper
• Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach

  2019cited by this paper
• Identification of potential histone deacetylase1 (HDAC1) inhibitors using multistep virtual screening approach including SVM model, pharmacophore modeling, molecular docking and biological evaluation

  2019cited by this paper
• Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase

  2019cited by this paper
• Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy

  2019cited by this paper
• Identification of Novel PI3Kδ Selective Inhibitors by SVM-Based Multistage Virtual Screening and Molecular Dynamics Simulations

  2019cited by this paper
• Identification of novel CDK2 inhibitors by a multistage virtual screening method based on SVM, pharmacophore and docking model

  2019cited by this paper
• Sphingosine kinase 1/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson’s disease

  2018cited by this paper
• Sphingosine kinase 1 promotes liver fibrosis by preventing miR‐19b‐3p‐mediated inhibition of CCR2

  2018cited by this paper
• Sphingosine kinase inhibitors: A patent review.

  2018cited by this paper
• Machine Learning-based Virtual Screening and Its Applications to Alzheimer’s Drug Discovery: A Review

  2018cited by this paper
• The Enigma of Sphingolipids in Health and Disease

  2018cited by this paper
• QSAR classification-based virtual screening followed by molecular docking studies for identification of potential inhibitors of 5-lipoxygenase

  2018cited by this paper
• Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression.

  2018cited by this paper
• Astragaloside IV promotes the proliferation and migration of osteoblast-like cells through the hedgehog signaling pathway

  2018cited by this paper
• Meta-QSAR: a large-scale application of meta-learning to drug design and discovery

  2017cited by this paper
• Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System

  2017cited by this paper
• Multiple machine learning based descriptive and predictive workflow for the identification of potential PTP1B inhibitors.

  2017cited by this paper
• Sphingolipid metabolism in cancer signalling and therapy

  2017cited by this paper
• Sphingosine kinase 1 expression enhances colon tumor growth

  2017cited by this paper
• Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells

  2017cited by this paper
• Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade

  2017cited by this paper
• Lack of Adipocyte-Fndc5/Irisin Expression and Secretion Reduces Thermogenesis and Enhances Adipogenesis

  2017cited by this paper
• Virtual screening approach to identifying influenza virus neuraminidase inhibitors using molecular docking combined with machine-learning-based scoring function

  2017cited by this paper
• Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits.

  2017cited by this paper
• Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease

  2017cited by this paper
• Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells

  2017cited by this paper
• Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling.

  2017cited by this paper
• Sphingosine Kinase 1: A Potential Therapeutic Target in Pulmonary Arterial Hypertension?

  2017cited by this paper
• Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma

  2016cited by this paper
• Supplemental Information Sphingosine kinases : emerging structure-function insights

  2016cited by this paper
• AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways

  2016cited by this paper
• Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis.

  2016cited by this paper
• Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543.

  2016cited by this paper
• RETRACTED ARTICLE: Overexpression of SphK1 enhances cell proliferation and invasion in triple-negative breast cancer via the PI3K/AKT signaling pathway

  2016cited by this paper
• A novel role of sphingosine kinase‐1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma

  2015cited by this paper
• Multistage virtual screening and identification of novel HIV-1 protease inhibitors by integrating SVM, shape, pharmacophore and docking methods.

  2015cited by this paper
• SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.

  2015cited by this paper
• Sphingolipids in viral infection

  2015cited by this paper

• Discovery and Characterization of Novel Receptor-Interacting Protein Kinase 1 Inhibitors Using Deep Learning and Virtual Screening.

  2025cites this paper